Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma

Carcinogenesis

Volumn 28, Issue 12, 2007, Pages 2614-2623

  Poutahidis, Theofilos ^a,d   Haigis, Kevin M ^a,e   Rao, Varada P ^a   Nambiar, Prashant R ^a   Taylor, Christie I ^a   Ge, Zhongming ^a   Watanabe, Koichiro ^a   Davidson, Anne ^b,f   Horwitz, Bruce H ^c   Fox, James G ^a   Erdman, Susan E ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYBRID PROTEIN; IMMUNOGLOBULIN G2A; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER TISSUE; CHRONIC INFLAMMATION; COLITIS; COLON CARCINOGENESIS; COLON CARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENDER BIAS; IMMUNOCOMPETENT CELL; LYMPHOCYTE TRANSFER; MICROORGANISM; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD4; CELL TRANSFORMATION, NEOPLASTIC; COLITIS; COLONIC NEOPLASMS; HELICOBACTER HEPATICUS; HELICOBACTER INFECTIONS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MICE; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; T-LYMPHOCYTES, REGULATORY;

EID: 36949006791     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm180     Document Type: Article

References (55)

1. American Cancer Society. US Public Health Service. US Cancer Facts and Figures, (2004). ACS.
2. Ming,S. (1998) Malignant epithelial tumors of the intestines. In Ming,S.-C. and Goldman,H. (eds.) Pathology of the Gastrointestinal Tract. Williams & Wilkins, Baltimore, MD, pp. 855-898.
3. Hanski,C. (1995) Is mucinous carcinoma of the colorectum a distinct genetic entity? Br. J. Cancer, 72, 1350-1356.
4. Okuno,M. et al. (1988) Mucinous colorectal carcinoma: Clinical pathology and prognosis. Am Surg., 54, 681-685.
5. Minsky,B.D. et al. (1987) Colloid carcinoma of the colon and rectum. Cancer, 60, 3103-3112.
6. Erdman,S.E. et al. (2003) CD4+CD25+ regulatory t lymphocytes inhibit microbially-induced colon cancer in Rag2-deficient mice. Am J. Pathol., 162, 691-702.
7. Erdman,S.E. et al. (2003) CD4+CD25+ regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res. 63, 6042-6050.
8. Powrie,F. (1995) T cells in inflammatory bowel disease: Protective and pathogenic roles. Immunity, 3, 171-174.
9. Maloy,K. et al. (2003) CD4+CD25+ Tr cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med., 197, 111-119.
10. Boivin,G.P. et al. (2003) Pathology of mouse models of intestinal cancer: Consensus report and recommendations. Gastoenterology, 12A, 762-777.
11. Fox,J.G. et al. (1994) Helicobacter hepaticus species.nov. a microaerophilic bacterium isolated from livers and intestinal mucosal scmpings from mice. J. Clin. Micro., 32, 1238-1245.
12. Mihara,M. et al. (2000) CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus. J. Clin. Invest. 106, 91-101.
13. 1. J. Immunol., 177, 7332-7339.
14. Rao,V.P. et al. (2006) Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res., 66, 7395-7400.
15. Berg,D.J. et al. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest., 98 1010-1020.
16. Whitehead,R.H. et al. (1999) Clonogenic growth of epithelial cells from normal colonic mucosa from both mice and humans. Gastroenterology, 117, 858-865.
17. Maloy,K.J. et al. (2005) Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells. Immunol. Lett., 97 189-192.
18. Kullberg,M.C. et al. (1999) Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun., 66, 5157-5166.
19. Kullberg,M.C. et al. (2002) Bacteria-triggered CD4+ T regulatory cells suppress Helicobacter hepaticus-induced colitis. J. Exp. Med., 196, 505-1115.
20. Hori,S. et al. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057-1061.
21. Banham,A.H. et al. (2006) FOXP3+ regulatory T cells: Current controversies and future perspectives. Eur. J. Immunol., 36, 2832-2836.
22. Maul,J. et al. (2005) Peripheral and intestinal regulatory CD4+ CD25 (high) T cells in inflammatory bowel disease. Gastroenterology 128, 1868-1878.
23. Ling,K.L. et al. (2007) Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun., 7, 7.
24. Zheng,X.X. et al. (1995) Administration of a noncytolytic IL10-Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J. Immunol., 154, 5590-5600.
25. Rao,V.P. et al., (2006) Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res., 66, 57-61.
26. Luo,J.L. et al. (2004) Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell, 6, 297-305.
27. Balkwill,F. et al. (2004) Cancer: An inflammatory link. Nature 431, 405-406.
28. Smith,P.C. et al. (2001) Interleukin 6 and prostate cancer progression. Cytokine Growth Factor Rev., 12, 33-40.
29. Scheller,J. et al. (2006) Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand. J. Immunol., 63, 321-329.
30. Massague,J. et al. (2000) TGFb signlaing in growth control, cancer, and heritable disorders. Cell, 103, 295-309.
31. Engle,S.J. et al. (2002) Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res., 62, 6362-6366.
32. Engle,S.J. et al. (1999), Transforming growth factor beta-1 suppresses non-metastatic colon cancer at an early stage of tumorigenesis. Cancer Res., 59; 3379-3386.
33. Kim,O. et al. (2004) Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells. Oncogene, 23, 1838-1844.
34. Powrie,F. et al. (2003) Regulating the regulators. Science, 299, 1030-1031.
35. Moore,K.W. et al. (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol., 19, 683-765.
36. Lin,W.W. et al. (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest., 117, 1175-1183.
37. Erdman,S.E. et al. (2005) CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res., 65, 3998-4004.
38. Rodriguez-Molinero,A. et al. (2007) Tissue homeostasis and cancer. Med. Hypotheses, 68, 1333-1341.
39. Curiel,T.J. et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med., 10, 942-949.
40. O'Garra,A. et al. (2004) IL-10-producing and naturally occurring CD4+ Tregs: Limiting collateral damage. J. Clin. Invest., 114 1372-1378.
41. Dvorak,H.F. (1986) Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med., 315, 1650-1659.
42. Martin,P. (1997) Wound healing - aiming for perfect skin regeneration. Science, 276, 75-81.
43. Crowe,M.J. et al. (1998) Review of case definitions for nosocomial infection - towards a consensus. Presentation by the Nosocomial Infection Surveillance Unit (NISU) to the Hospital Infection Liaison Group, sub-committee of the Federation of Infection Societies (FIS). J. Hosp. Infect., 39, 341.
44. Fuss,I.J. et al. (2001) The Interrelated roles of TGF-b and IL10 in the regulation of experimental colitis. J. Immunol., 168, 900-908.
45. Ruiz,P.A. et al. (2005) EL-10 gene-deficient mice lack TGF-beta/ Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J. Immunol., 174, 2990-2999.
46. Maggio-Price,L. et al. (2005) Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-l- mice results in colitis that progresses to dysplasia. Am. J. Pathol., 166, 1793-1806.
47. Maggio-Price,L. et al. (2006) Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res., 66, 828-838.
48. Pasche,B. (2001) Role of transforming growth factor beta in cancer. J. Cell, Physiol., 186, 153-168.
49. Faubion,W.A. et al. (2004) Colitis is associated with thymic destruction attenuating CD4+CD25+ regulatory cells in the periphery. Gastroenterology, 126, 1759-1770.
50. Becker,C. et al. (2004) TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity, 21, 491-501.
51. Corvinus,F.M. et al. (2005) Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia, 7, 545-555.
52. Hurst,S.M. et al. (2001) Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity, 14, 705-714.
53. Vieira,P.L. et al. (2004) Il- 10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to natura occuring CD4+CD25+ regulatory T cells. J. Immunol., 172, 5986-5993.
54. Blattman,J.N. et al. (2004) Cancer immunotherapy b: A treatment for the masses. Science, 305, 200-205.
55. Chin,L. et al. (1999) Essential role for oncogenic Ras in tumour maintenance. Nature, 400, 468-472.